Futu News reported on March 14 that all three major indices of Hong Kong stocks were adjusted. At the close, the Hang Seng Index fell 0.71%, the Science Index fell 1.44%, and the China Index fell 0.43%.
By the close, Hong Kong stocks were up 750, down 1,213, and closed at 1,024.
The specific industry performance is as follows:
On the sector side, TechNet stocks declined collectively, with Bilibili falling nearly 4%, Kuaishou falling more than 2%, Meituan and Xiaomi falling more than 1%, and Ali, Tencent, and Baidu.
Most auto stocks weakened. Xiaopeng fell nearly 6%, NIO fell nearly 5%, Ideal fell nearly 2%, and Zero Run and Geely fell slightly.
Domestic housing stocks and property management stocks diverged. Xuhui Holdings and China Resources Land rose more than 3%, Longhu Group rose more than 2%, and Country Garden Services and Ocean Group fell more than 1%.
Gold stocks rose against the market. China Gold International rose more than 6%, Zijin Mining rose more than 3%, and Shandong Gold and Zhaojin Mining rose more than 1%.
Petroleum stocks generally rose; CNOOC oil field services rose more than 7%, Sinopec and CNPC rose more than 2%, and CNOOC rose nearly 1%.
CRO concept stocks had mixed ups and downs. Tiger Pharmaceuticals rose more than 20%, Zhaoyan Pharmaceutical rose more than 12%, Pharmaceutical Biotech fell more than 13%, Pharmaceutical Kangde fell more than 12%, and Kingsley Biotech fell more than 3%.
On the other hand, Apple concept stocks declined collectively; PV stocks, semiconductor stocks, domestic insurance stocks, and Chinese brokerage stocks performed poorly.
In terms of individual stocks,$CHINAGOLDINTL (02099.HK)$With an increase of more than 6%, the price of Motong Daikan is expected to rise to 2,500 US dollars this year.
$SAMSONITE (01910.HK)$It rose more than 3%, and net profit increased 33.3% year-on-year to US$417 million last year.
$XPENG-W (09868.HK)$It fell nearly 6%, short-term sales were still under pressure, and the core management team changed.
$WUXI BIO (02269.HK)$With a drop of more than 13%, US BIO said it would remove the Medicinal Kangde membership.
Today's top 10 Hong Kong stock turnover
Hong Kong Stock Connect Capital
On the Hong Kong Stock Connect side, today's net inflow of Hong Kong Stock Connect (southbound) was HK$2,601 billion.
Agency Perspectives
Xiaomo: The Bank of China expects revenue growth to beat expectations last quarter, favoring China Merchants Bank and the four major state-owned banks
J.P. Morgan Chase released a research report saying that the Bank of China will begin announcing results on March 14. It is expected that various banks will show different profit growth trends, and the market will focus more on this year's prospects than on the fourth quarter of last year's performance. After entering the performance period, the bank is more preferred$CM BANK (03968.HK)$And the four major domestic banks, because the profits of the four major domestic banks are more visible.
Goldman Sachs: Giving Ideal Automobile-W “Buy” Rating, Target Price HK$215
Goldman Sachs released a research report saying,$LI AUTO-W (02015.HK)$“Buy” rating, target price HK$215. The company has upgraded various equipment for the L series models, and the new recommended retail prices for the L7 and L8 are 18,000, 20,000, and 30,000 yuan lower than last year's Air/Pro/Max versions, respectively.
Nomura: Hanson Pharmaceuticals downgraded to “hold” and target price increased to HK$15.03
Nomura released a research report saying that it will$HANSOH PHARMA (03692.HK)$The rating was downgraded from “buy” to “hold”, and the target price was increased by 15.5% to HK$15.03 from HK$13.01. According to the report, the company's revenue forecast for the 2023 and 2024 fiscal years was 1% and 3% higher than the agency's. Considering high-profit advance payments, the net profit forecast for 2023 and 2024 was raised by 17.7% and 28.5%, respectively, which is higher than the agency's average forecast.
editor/tolk